Charles River has been leading the way in the development, validation and acceptance of various animal-free models. Many of our assays are direct replacements for tests or screenings done on animals. Depending on your needs, we can test individual ingredients, mixtures or final products. Our range of model systems results in multiple toxicology endpoints for better decision making at the lead optimization stage of testing, which provides endpoints for registration dossiers under REACH. 

You may also be interested in...

Miss Us at SOT 2016?

Access the recordings of our three exhibitor sessions and downloadable versions of our poster presentations from SOT 2016.

Ion Channel Discovery Services

The acquisition of ChanTest significantly broadens our existing discovery-focused ion channel capabilities, enhancing our ability to support clients' target discovery and lead optimization efforts.

In Vitro Mechanistic and Replacement Models

Screening in vitro models are generating improved drug candidates for selection into preclinical testing. These, and other tests, continue to help achieve the 3Rs goals.